Table III | ||
FY 2010 GUIDANCE AND FY 2009 EPS | ||
RECONCILIATION OF NON-GAAP MEASURES | ||
(unaudited) | ||
Full Year* | ||
Fiscal 2010 Guidance | ||
FY10 reported diluted earnings per share from continuing operations range | $2.42 - $2.47 | |
Charges associated with inventory step-ups | 0.050 | |
Charge associated with acquired research and development | 0.123 | |
Charges associated with acquisition costs | 0.081 | |
Charges associated with restructuring | 0.078 | |
FY10 adjusted diluted earnings per share from continuing operations range | $2.75 - $2.80 | |
Fiscal 2009* | ||
FY09 reported diluted earnings per share from continuing operations | $1.67 | |
Loss on asset exchange | 0.007 | |
Charges associated with inventory step-ups | 0.021 | |
Fixed asset impairment | 0.011 | |
Write-off of in-process R&D | 0.002 | |
Investment impairment | 0.161 | |
FY09 adjusted diluted earnings per share from continuing operations | $1.87 | |
*All information based on continuing operations. | ||